Showing results (31-40 of 37) with videos related to
Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 37 results.
Anticancer Research|December 8, 2020
Delay in Breast Cancer Treatments During the First COVID-19 Lockdown. A Multicentric Analysis of 432 PatientsGianluca Vanni, Giovanni Tazzioli, Marco Pellicciaro, et al.Breast Cancer (Tokyo, Japan)|September 8, 2016
Current trends and outcomes of breast reconstruction following nipple-sparing mastectomy: results from a national multicentric registry with 1006 cases over a 6-year periodDonato Casella, Claudio Calabrese, Lorenzo Orzalesi, et al.International Journal of Cancer|November 11, 2010
High RAD51 mRNA expression characterize estrogen receptor-positive/progesteron receptor-negative breast cancer and is associated with patient's outcomeRaffaela Barbano, Massimiliano Copetti, Giuseppe Perrone, et al.In Vivo (Athens, Greece)|June 7, 2020
The Effect of Coronavirus (COVID-19) on Breast Cancer Teamwork: A Multicentric SurveyGianluca Vanni, Marco Materazzo, Francesca Santori, et al.Oncotarget|April 21, 2017
Limitations in predicting PAM50 intrinsic subtype and risk of relapse score with Ki67 in estrogen receptor-positive HER2-negative breast cancerAranzazu Fernandez-Martinez, Tomás Pascual, Giuseppe Perrone, et al.European Journal of Cancer (Oxford, England : 1990)|April 1, 2026
Denosumab is associated with longer real-world progression-free survival in BRCA1/2-mutated HR+ /HER2 - breast cancer patients with bone metastases receiving CDK4/6 inhibitors: A multicenter Italian studyRoberta Scafetta, Raffaella Troiano, Carla Gullotta, et al.The Oncologist|April 17, 2026
Comparative real-world Progression Free Survival of CDK4/6 Inhibitors in HR+/HER2- Breast Cancer Patients with Bone MetastasesRoberta Scafetta, Marco Donato, Carla Gullotta, et al.Pageof 4